D-0198-2021 Class II Terminated

Recalled by SCA Pharmaceuticals — Windsor, CT

Recall Details

Product Type
Drugs
Report Date
January 13, 2021
Initiation Date
December 17, 2020
Termination Date
November 2, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,057 syringes

Product Description

labetalol HCl 20 mg/4 mL, Injection for Intravenous Use (5mg/mL), Rx Only, 4 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004070028

Reason for Recall

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Distribution Pattern

Product was distributed to hospitals nationwide.

Code Information

Lot # 1220022969, BUD 3/1/2021; 1220023002, BUD 3/2/2021; 1220023045, BUD 3/2/2021; 1220023081, BUD 3/2/2021; 1220023130, BUD 3/6/2021; 1220023229, BUD 3/9/2021; 1220023287, BUD 3/12/2021 & 1220023335, BUD 3/22/2021.